Picture of Memphasys logo

MEM — Memphasys News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Memphasys eyes best day in nearly a year on signing distribution agreement

** Shares of Australia's Memphasys Ltd  MEM.AX  rise as much
as 25.9% to A$0.017, set to mark best day since Aug. 22, 2022,
if current gains hold  
    ** Stock hits highest since July 14 
    ** Reproductive biotechnology co signs exclusive agreement
with Vitrolife Japan KK to sell and distribute the Felix™ System
(Felix™) in Japan 
    ** Felix™ is an automated device with single-use cartridges
for preparing sperm for human IVF procedures
    ** Adds agreement provides Vitrolife KK the exclusive right
to sell and distribute the FelixTM system in Japan
    ** Stock has fallen 3.6% this year as of last close

 (Reporting by Nausheen Thusoo in Bengaluru)
 ((Nausheen.Thusoo@thomsonreuters.com;))

Recent news on Memphasys

See all news